Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

Objectives To determine the relationship between non–high-density lipoprotein cholesterol (HDL-C) lowering and coronary heart disease (CHD) risk reduction for various lipid-modifying therapies. Background Non–HDL-C is the second lipid target of therapy after low-density lipoprotein cholesterol (LDL-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2009-01, Vol.53 (4), p.316-322
Hauptverfasser:	Robinson, Jennifer G., MD, MPH, Wang, Songfeng, MS, Smith, Brian J., PhD, Jacobson, Terry A., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Atherosclerosis Biological and medical sciences Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Cholesterol Cholesterol, HDL - blood Cholesterol, LDL - blood Clofibric Acid - therapeutic use Confidence intervals Coronary Disease - blood Coronary Disease - drug therapy Coronary heart disease Diabetes Disease prevention Disorders of blood lipids. Hyperlipoproteinemia Female fibrates Heart Heart attacks Heart surgery Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Internal Medicine Lipids Lipoproteins Male Medical sciences Meta-analysis Metabolic diseases niacin Niacin - therapeutic use non–HDL-cholesterol Risk Factors Statins Statistical methods Stroke Studies Vitamin B
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!